American Journal of Clinical Oncology · 2008 · 41 citations · 20 references
MedicineHematologyOncologyDiagnostic ImagingDiagnostic RadiologyOncologic ImagingBone Marrow EvaluationBone Marrow PathologyHematologic MalignanciesLymphoid NeoplasmsLymphoma ImagingPositron Emission Tomography18F-fluorodeoxyglucose Positron Emission TomographyBone Marrow AssessmentBone Marrow Involvement AssessmentBone Marrow Lesion AssessmentBone Marrow StagingFluorine-18 Fluorodeoxyglucose Positron Emission TomographyLymphoma Bone Marrow InvolvementWhole-body Pet Imaging
PURPOSE: In non-Hodgkin lymphomas (NHLs), the bone marrow (BM) involvement is a sign of extensive disease and the iliac crest BM biopsy (BMB) is the established method for the detection of BM infiltration. However, iliac crest BMB is associated with a high rate of false negative results. We assess the ability of 18-F-fluorodeoxyglucose positron emission tomography (F-FDG PET) scan to ascertain the presence of BM involvement in NHL. METHODS: After reviewing charts of histologically proven NHLs, 97 patients were eligible for our study. All patients were examined by whole-body F-FDG PET scan for initial staging, and all had unilateral posterior iliac crest BMB. BM involvement was established after the result of unilateral posterior iliac crest BMB and image-guided BMB after positive F-FDG PET scan in selected patients. RESULTS: Our data demonstrate an overall sensitivity of 79% for the F-FDG PET scan detecting BM involvement in all patients and specificity of 91%. Further analysis revealed no significant difference in the ability of the F-FDG PET scan to detect BM involvement between the indolent-NHL and the aggressive/highly aggressive-NHL groups (sensitivity P = 0.23, specificity P = 0.64). CONCLUSION: F-FDG PET scan shows potential to detect BM involvement in NHL. In particular, image-guided repeat BMB should be considered in patients with negative initial iliac crest BMB, whose F-FDG PET scan demonstrates BM involvement in a different site.
20
Utility of FDG-PET scanning in lymphoma by WHO classification
Rebecca Elstrom, Liang Guan, Gary Baker et al. · Blood · 2003 · 437 citations · Full text
Medicine, Nuclear Medicine, Oncology +12
Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
Joel S. Newman, Isaac R. Francis, Mark Kaminski et al. · Radiology · 1994 · 267 citations